Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Beckman Coulter
| Company | Beckman Coulter |
|---|---|
| Name of analyzer | DxH 900 Workcell Automated Hematology Solution |
| Contact | Eric Pabon |
| City, State | Brea, CA |
| Phone | 714-993-5321 |
| Website | 714-993-5321 http://www.beckmancoulter.com |
| Analyzer application | diagnostic and research use |
| Dimensions of analyzer (H × W × | 80.5 × 67 × 33 in. (includes slide maker stainer)/18.9 sq. ft. |
| Country where analyzer was | U.S./U.S. |
| First year analyzer was sold in U.S./Approximate No. of units installed in U.S.* | 2018/>1, 200 |
| First year analyzer sold outside | 2018/>2, 450 |
| Foreign locations where company | worldwide (installed worldwide) |
| Human languages (other than | Japanese, Chinese, French, Italian, German, Spanish, Portuguese, Swedish, Greek, Czech, Hungarian, others |
| Analyzer list price | $690, 000 (slide maker stainer sold separately) |
| • Analyzer acquisition options | purchase, lease |
| Training included with purchase/Total time for basic training per operator | 30 min. daily |
| • Follow-up training available | yes (extra charge) |
| Parameters that analyzer tests and reports | %&# eosinophils, %&# lymphocytes, %&# monocytes, %&# neutrophils, %&# basophils, %&# reticulocyte count, Hb, Hct, MCH, MCHC, MCV, PLT, RBC, NRBC, WBC |
| Types of testing FDA cleared or approved for analyzer | blood count analysis, body fluid analysis |
| Types of body fluids FDA cleared or approved for analysis on analyzer | CSF, synovial fluid, serous fluid |
| Analytical measurement range for body fluid | RBC count: 1, 000–6, 200, 000 cells/mm3; TNC count: 20–89, 000 cells/mm3 |
| Precision for body fluid | RBC count: 10, 000–15, 000 cells/mm3; TNC count: 50–2, 000 cells/mm3 |
| Accuracy for body fluid | RBC count: 1, 000–6, 200, 000 cells/mm3; 20–89, 000 cells/mm3 |
| Automated differential performed for body fluids | no |
| Tests available for research use only | body fluid mononuclear cell %, more |
| Differential methods used | prepared sample transferred to multi-transducer module, with cells counted in an isometric sample stream; algorithm analysis separates WBC into 5 populations |
| Analytical measurement range: • WBC count/RBC count | WBC: 0.050–400.000 × 103 cells/μL/RBC: 0.005–8.500 × 106 cells/μL |
| Precision: • WBC count/RBC count | WBC: 05.00–2.000 × 103 cells/μL: ≤5.0% CV; 5.000–10.000 × 103 cells/μL: ≤3.0% CV/RBC: 4.500–5.500 × 106 cells/μL |
| Accuracy: • WBC count/RBC count | WBC: 0.050–2.000 × 103 cells/μL ±0.1 or ±10%; >2.000–100.000 × 103 cells/μL ±0.2 or ±3.0%; >100.00–400.00 × 103 cells/μL ±5.0%/RBC: 0.005–8.500 × 106 cells/μL |
| Interfering substances: • WBC/RBC | NRBCs, giant platelets, platelet clumps, malarial parasites, precipitated elevated proteins, more/very high WBC count, concentration of very large platelets, autoagglutination |
| • Hemoglobin/Platelets | severe lipemia, heparin, certain unusual RBC abnormalities that resist lysing/giant platelets, platelet clumps, WBC and RBC fragments, electronic noise, very small RBCs |
| • Hematocrit/Reticulocytes | very high WBC count, high concentration of very large platelets, more/erythrocyte inclusions stained by new methylene blue if sufficiently numerous within sample, more |
| • Automated differential | hypogranular granulocytes, agranular granulocytes, lyse-resistant RBCs, elevated triglycerides, more |
| Throughput: max. CBCs per hour/Max. CBCs with differentials per hour | 100–300, based on module/100–300, based on module |
| • Max. No. of slides processed per hour if stainer included | 140 |
| FDA-cleared or -approved sample container types (besides potassium EDTA) | none |
| Min. specimen volume open mode/Closed mode/Microsample capability | 165 μL/165 μL/yes |
| Types of patient data archived/Max. No. of archived patient data accessible when analyzer online | results, including graphics, raw data files/100, 000 |
| Analyzer performs delta checks | yes |
| Parameters for which flags may appear | delta checks, reference range flags, action limit flags, critical limit flags, suspect messages, more |
| Analyzer recognizes and holds test results | yes, for follow-up, confirmatory testing, and potential test rerun (parameters for flags to hold samples defined by client or vendor) |
| Scattergram display uses cell-specific color | yes |
| Histogram display uses color with thresholds | yes |
| LIS interface formats supported | proprietary (analyzer or vendor specific), ASTM 1394-91, ASTM 1238-95, IEEE MIB |
| • Middleware interface | yes (can use company’s middleware) |
| • Information transferred to LIS via middleware or LIS interface | numeric results, flagged results, histograms, scatterplots, patient demographics, patient orders, more |
| Analyzer transmits LOINC codes for results to LIS or middleware | yes (also provides list of machine codes for each test and corresponding LOINC code) |
| Lab automation system or workcells to which analyzer has a direct interface | Beckman Coulter |
| Barcode symbologies read on specimen tube | Codabar, Code 39, Code 128, Interleaved 2 of 5, NW-7, ASTM |
| • Analyzer allows barcode placement per CLSI standard Auto02-A2 | yes |
| No. of onboard reagents required for standard specimen analysis | 4 |
| • Reagents ready to use/Reagent tracking method | yes/barcode reader |
| Onboard diagnostics for troubleshooting | yes |
| • Manufacturer can perform diagnostics via remote access | yes |
| Warranty provided/Cost of annual service contract (24 h/7 d) | one-year warranty/variable |
| Notes | — |